ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/03/01 | 1,369 | 1,369 | 1,337 | 1,343 | -17 | -1.3% | 10,000 |
2012/02/29 | 1,354 | 1,368 | 1,352 | 1,360 | -6 | -0.4% | 17,000 |
2012/02/28 | 1,356 | 1,370 | 1,356 | 1,366 | +8 | +0.6% | 35,000 |
2012/02/27 | 1,348 | 1,358 | 1,346 | 1,358 | +23 | +1.7% | 15,000 |
2012/02/24 | 1,352 | 1,357 | 1,334 | 1,335 | -15 | -1.1% | 20,000 |
2012/02/23 | 1,336 | 1,350 | 1,336 | 1,350 | +15 | +1.1% | 10,000 |
2012/02/22 | 1,344 | 1,348 | 1,335 | 1,335 | +4 | +0.3% | 19,000 |
2012/02/21 | 1,347 | 1,347 | 1,329 | 1,331 | -17 | -1.3% | 5,000 |
2012/02/20 | 1,348 | 1,348 | 1,345 | 1,348 | ±0 | ±0% | 11,000 |
2012/02/17 | 1,333 | 1,352 | 1,333 | 1,348 | +16 | +1.2% | 20,000 |
2012/02/16 | 1,346 | 1,347 | 1,332 | 1,332 | -24 | -1.8% | 7,000 |
2012/02/15 | 1,349 | 1,356 | 1,349 | 1,356 | +7 | +0.5% | 17,000 |
2012/02/14 | 1,343 | 1,349 | 1,343 | 1,349 | +6 | +0.4% | 13,000 |
2012/02/13 | 1,326 | 1,343 | 1,326 | 1,343 | +18 | +1.4% | 8,000 |
2012/02/10 | 1,332 | 1,332 | 1,325 | 1,325 | -9 | -0.7% | 6,000 |
2012/02/09 | 1,318 | 1,336 | 1,318 | 1,334 | -9 | -0.7% | 13,000 |
2012/02/08 | 1,345 | 1,350 | 1,338 | 1,343 | +8 | +0.6% | 31,000 |
2012/02/07 | 1,341 | 1,343 | 1,335 | 1,335 | -8 | -0.6% | 10,000 |
2012/02/06 | 1,336 | 1,343 | 1,336 | 1,343 | +20 | +1.5% | 6,000 |
2012/02/03 | 1,343 | 1,343 | 1,322 | 1,323 | -21 | -1.6% | 6,000 |
2012/02/02 | 1,330 | 1,350 | 1,316 | 1,344 | +27 | +2.1% | 17,000 |
2012/02/01 | 1,325 | 1,326 | 1,310 | 1,317 | -8 | -0.6% | 5,000 |
2012/01/31 | 1,312 | 1,338 | 1,311 | 1,325 | +14 | +1.1% | 11,000 |
2012/01/30 | 1,315 | 1,315 | 1,311 | 1,311 | -4 | -0.3% | 6,000 |
2012/01/27 | 1,350 | 1,350 | 1,315 | 1,315 | -31 | -2.3% | 22,000 |
2012/01/26 | 1,319 | 1,348 | 1,312 | 1,346 | +27 | +2% | 20,000 |
2012/01/25 | 1,287 | 1,319 | 1,287 | 1,319 | +34 | +2.6% | 11,000 |
2012/01/24 | 1,298 | 1,300 | 1,285 | 1,285 | -25 | -1.9% | 6,000 |
2012/01/23 | 1,298 | 1,318 | 1,298 | 1,310 | -4 | -0.3% | 8,000 |
2012/01/20 | 1,309 | 1,314 | 1,303 | 1,314 | -3 | -0.2% | 16,000 |
2012/01/19 | 1,313 | 1,340 | 1,306 | 1,317 | -21 | -1.6% | 16,000 |
2012/01/18 | 1,305 | 1,338 | 1,305 | 1,338 | +11 | +0.8% | 17,000 |
2012/01/17 | 1,327 | 1,331 | 1,327 | 1,327 | -1 | -0.1% | 10,000 |
2012/01/16 | 1,337 | 1,337 | 1,328 | 1,328 | -29 | -2.1% | 8,000 |
2012/01/13 | 1,358 | 1,359 | 1,349 | 1,357 | +6 | +0.4% | 7,000 |
2012/01/12 | 1,346 | 1,360 | 1,300 | 1,351 | -7 | -0.5% | 33,000 |
2012/01/11 | 1,375 | 1,375 | 1,358 | 1,358 | -15 | -1.1% | 4,000 |
2012/01/10 | 1,350 | 1,376 | 1,350 | 1,373 | +23 | +1.7% | 20,000 |
2012/01/06 | 1,340 | 1,360 | 1,340 | 1,350 | +10 | +0.7% | 25,000 |
2012/01/05 | 1,349 | 1,349 | 1,340 | 1,340 | -5 | -0.4% | 10,000 |
2012/01/04 | 1,330 | 1,345 | 1,318 | 1,345 | +16 | +1.2% | 18,000 |
2011/12/30 | 1,326 | 1,329 | 1,312 | 1,329 | +3 | +0.2% | 14,000 |
2011/12/29 | 1,303 | 1,326 | 1,281 | 1,326 | +23 | +1.8% | 9,000 |
2011/12/28 | 1,318 | 1,318 | 1,300 | 1,303 | -8 | -0.6% | 9,000 |
2011/12/27 | 1,319 | 1,319 | 1,310 | 1,311 | -7 | -0.5% | 3,000 |
2011/12/26 | 1,315 | 1,330 | 1,303 | 1,318 | +12 | +0.9% | 16,000 |
2011/12/22 | 1,303 | 1,315 | 1,301 | 1,306 | +36 | +2.8% | 39,000 |
2011/12/21 | 1,276 | 1,276 | 1,270 | 1,270 | -5 | -0.4% | 2,000 |
2011/12/20 | 1,271 | 1,275 | 1,262 | 1,275 | +4 | +0.3% | 11,000 |
2011/12/19 | 1,302 | 1,302 | 1,267 | 1,271 | -14 | -1.1% | 14,000 |
3301~
3350
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム